April 17, 2014 4:31 AM ET


Company Overview of Topigen Pharmaceuticals, Inc.

Company Overview

Topigen Pharmaceuticals, Inc., a respiratory biopharmaceutical company, engages in the development of inhaled therapeutics for respiratory disorders. The company focuses on novel and synergistic topical products for asthma, COPD, allergic rhinitis, and associated conditions with unmet therapeutic needs. Its products include TPI ASM8, an inhaled drug for treating multiple inflammatory cytokine receptors, such as asthma; and TPI ARL8, a nasal spray for treating multiple inflammatory cytokine receptors, comprising allergic rhinitis. The company’s products also include TPI 1020, an inhaled nitric-oxide form of budesonide inhibiting neutrophils; and TPI 1100, an inhaled inhibitor of PDEs involved...

4050 Molson Street

Suite 300

Montreal, QC H1Y 3N1


Founded in 2000





Key Executives for Topigen Pharmaceuticals, Inc.

Chief Executive Officer
Chief Business Officer
Age: 57
Director of Finance
Director of Preclinical Development
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
PharmaNutrients Botanical Corporation Americas
Vert Medical - Green Medical Inc. Americas
PharmaSpritz Corporation Americas
Centaur Pharmaceuticals Inc. Americas
Cronus BioPharma Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Topigen Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.